EPH247 Pain and Arthralgia Adverse Events Associated with Crizanlizumab and Voxelotor: Disproportionality Analysis of US FDA Adverse Events Reporting System (FAERS)
Abstract
Authors
A. Ologunowa A.R. Caffrey
A. Ologunowa A.R. Caffrey
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now